Categories: News

TE Connectivity announces 9% increase in quarterly cash dividend to $0.71

Shareholders reelect all 12 members to board of directors during annual general meeting

GALWAY, Ireland, March 13, 2025 /PRNewswire/ — TE Connectivity plc (NYSE: TEL) announced today that its board of directors declared a regular quarterly cash dividend of $0.71 per ordinary share, payable on June 10, 2025, to shareholders of record at the close of business on May 21, 2025. This payment represents a 9% increase from the $0.65 per ordinary share quarterly dividend paid to shareholders on March 7.

In addition, during the company’s 2025 annual general meeting of shareholders held March 12, shareholders voted in favor of all agenda items, including the reelection of all 12 members to the board of directors.

About TE Connectivity
TE Connectivity plc (NYSE: TEL) is a global industrial technology leader creating a safer, sustainable, productive, and connected future. Our broad range of connectivity and sensor solutions enable the distribution of power, signal, and data to advance next-generation transportation, energy networks, automated factories, data centers, medical technology, and more. With more than 85,000 employees, including 9,000 engineers, working alongside customers in approximately 130 countries, TE ensures that EVERY CONNECTION COUNTS. Learn more at www.te.com and on LinkedIn, Facebook, WeChat, Instagram and X (formerly Twitter).

View original content to download multimedia:https://www.prnewswire.com/news-releases/te-connectivity-announces-9-increase-in-quarterly-cash-dividend-to-0-71–302401408.html

SOURCE TE Connectivity plc

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

59 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

59 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

4 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

5 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

19 hours ago